scPharmaceuticals Inc. SCPH

Feeling like todays price drop is a big over reaction, to what could be nothing at all. Especially due to their current and projected sales track and what today’s market cap is. Not to mention how big Q4 likely will be.

I just loaded up some more when it was down 10%, I’ll take the discount! Just made 5% on my investment in the past 1-2 hours!!

Once we get over 100 million in annual sales, they should be getting pretty close to profitable, and a strong buyout target. Keep in mind this drug keeps people from going back to the hospital, which costs the system a lot of money. This drug is a money saver for the system, and a quality of life enhancer for the patients who can treat themselves at home versus going back to the hospital for treatment of fluid overload.

Don’t we have another indication coming in February or March 2025. I think they said that the sales of that new indication should be about half of their total sales once all is said and done.

Crazy I have been able to add so much at such a cheap Price. They are knocking down barriers to coverage as we speak and by March no reason to think they will not have yet another indication.

Additional sales force is adding incremental sales which continue to build.

This drug is very much a quality of life enhancer, and a cost saving option to the health care system. Most would much rather treat at home than have to go into clinics or hospital for fluid overload.

2025 hold tremendous potential, happy to be buying hand over fist at under $4!

Considerably undervalued at this price. Unless you don’t think sales are gonna grow at all. And then I t’s about fair value.

I’m kind of amazed that the $5 November 15th calls are selling at $.20

Earnings call between Nov 6 -11th,

It would seem a reasonable multiple applied to their sales would easily put this over five dollars.

That aside leading up to the earnings call I can’t imagine that the shorts will not be covering hard with the Share price in the low 4s currently

I am looking forward to the next three earnings calls, each with multiple catalyst as tail winds to Sales

One thing is for certain, we’re going to see amazing sales growth, what exactly that looks like is left to be seen but share price will certainly react to the doubling and tripling of sales, which are certainly coming.

Enjoy the ride and pick up as many shares as you can in the four dollar range cause it ain’t gonna last long, in my opinion .

Great Ad with People magazine, it’s pretty much in every Dr office.

Just what is needed is a little advertising on the quality of life aspect of Furoscix. Nobody likes going to the hospital when they can treat themself at home!

What a deal going on, even at a 8m a quarter run rate, let alone the strong catalyst that will lift sales over each of the next 3-4 quarters.

Keep shorting , I’m buying!